Home

Dobyvatel jed Teoretický antitumor immune markers in diagnosis and treatment failure Lechtání Uzavřete pojištění zvýšit

Frontiers | The Mechanism of Stimulating and Mobilizing the Immune System  Enhancing the Anti-Tumor Immunity
Frontiers | The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity

Life | Free Full-Text | An Immunological Perspective of Circulating Tumor  Cells as Diagnostic Biomarkers and Therapeutic Targets
Life | Free Full-Text | An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets

Frontiers | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute  Lymphoblastic Leukemia
Frontiers | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia

Frontiers | Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and  Neoadjuvant
Frontiers | Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

What Are Immune Checkpoints?
What Are Immune Checkpoints?

Frontiers | Molecular Aspects and Future Perspectives of Cytokine-Based  Anti-cancer Immunotherapy
Frontiers | Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy

Circulating immune biomarkers in peripheral blood correlate with clinical  outcomes in advanced breast cancer | Scientific Reports
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer | Scientific Reports

Biology | Free Full-Text | Targets of Immune Escape Mechanisms in Cancer:  Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Biology | Free Full-Text | Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors

Nanoparticle-Based Immunotherapy for Cancer | ACS Nano
Nanoparticle-Based Immunotherapy for Cancer | ACS Nano

Cancers | Free Full-Text | Immune Checkpoint and Other Receptor-Ligand  Pairs Modulating Macrophages in Cancer: Present and Prospects
Cancers | Free Full-Text | Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects

Immunogenic cell death and its therapeutic or prognostic potential in  high-grade glioma | Genes & Immunity
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma | Genes & Immunity

Frontiers | What Happens to the Immune Microenvironment After PD-1  Inhibitor Therapy?
Frontiers | What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?

Cells | Free Full-Text | Metabolic Changes in Tumor Microenvironment: How  Could They Affect γδ T Cells Functions?
Cells | Free Full-Text | Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity  without autoimmunity | Cell Research
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity | Cell Research

Cells | Free Full-Text | The Immune Privilege of Cancer Stem Cells: A Key  to Understanding Tumor Immune Escape and Therapy Failure
Cells | Free Full-Text | The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure

Cancers | Free Full-Text | NSC243928 Treatment Induces Anti-Tumor Immune  Response in Mouse Mammary Tumor Models
Cancers | Free Full-Text | NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models

The Contribution of Epigenetics to Cancer Immunotherapy: Trends in  Immunology
The Contribution of Epigenetics to Cancer Immunotherapy: Trends in Immunology

Frontiers | Sensing Soluble Immune Checkpoint Molecules and Disease-Relevant  Cytokines in Cancer: A Novel Paradigm in Disease Diagnosis and Monitoring
Frontiers | Sensing Soluble Immune Checkpoint Molecules and Disease-Relevant Cytokines in Cancer: A Novel Paradigm in Disease Diagnosis and Monitoring

Frontiers | Therapeutic strategies for gastric cancer targeting immune  cells: Future directions
Frontiers | Therapeutic strategies for gastric cancer targeting immune cells: Future directions

Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs  the Tumor Microenvironment and Enhances the Antitumor Immune Response | ACS  Nano
Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs the Tumor Microenvironment and Enhances the Antitumor Immune Response | ACS Nano

Emerging new therapeutic antibody derivatives for cancer treatment | Signal  Transduction and Targeted Therapy
Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy

Advantages of targeting the tumor immune microenvironment over blocking  immune checkpoint in cancer immunotherapy | Signal Transduction and  Targeted Therapy
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy | Signal Transduction and Targeted Therapy

Reprogramming the anti-tumor immune response via CRISPR genetic and  epigenetic editing: Molecular Therapy - Methods & Clinical Development
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing: Molecular Therapy - Methods & Clinical Development

Systemic immunity in cancer | Nature Reviews Cancer
Systemic immunity in cancer | Nature Reviews Cancer

Laboratory biomarkers of an effective antitumor immune response. Clinical  significance. - ScienceDirect
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect

Frontiers | The Crosstalk Between Tumor Cells and the Immune  Microenvironment in Breast Cancer: Implications for Immunotherapy
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy